Breadcrumb Home Technology June 07, 2017 01:00 AM News from other sources... Modern Healthcare Tweet Share Share Email More Print Safety, quality and clinical practiceWHO creates controversial 'reserve' list of antibiotics for superbug threats | The Washington PostAs part of its efforts to stop the spread of superbugs, the WHO released the largest change to its recommendations in relation to "last resort" antibiotics.PharmaceuticalsAstraZeneca sells migraine drug for up to $302 million | ReutersAstraZeneca sold the drug to German company Grunenthal, adding to the number of drugs its sold or licensed recently.Medical devicesEko gets FDA clearance for digital stethoscope with ECG | Medcity NewsEko says the new stethoscope and heart monitor will be better for monitoring patients with heart conditions and that it could be used by patients for remote monitoring.Clarify gets FDA clearance for connected home phototherapy device | MobihealthnewsThe FDA has cleared Clarify Medical's consumer phototherapy device for use in the treatment of skin conditions, including psoriasis and eczema. Information technologyHHS issues warning for vigilance on WannaCry ransomware | Health Data ManagementTwo multi-state hospital systems are still dealing with the effects of last month's Wanna Cry ransomware attack, according to HHS.In other newsEven moderate drinking may speed brain decline | StatModerate drinking—between eight and 12 drinks per week—is linked to long-term changes in the brain, including shrinking of the hippocampus, a brain region that deals with memory and navigation, and degeneration of white matter in the brain. Letter to the Editor Send us a letter Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print. Recommended for You FDA approves the first COVID-19 point-of-care diagnostic test Health systems, tech giants tackle COVID-19 misinformation Sponsored Content View the discussion thread.